ALM Almirall, S.A.
10.10EUR-1.56%Mkt Cap: 2.39B $P/E: 30.611d ago
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, a…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.30BUSDP/E 25.0
$56.90BUSD
$46.26BUSDP/E 66.1
$38.79BUSDP/E 18.0
$29.51BUSDP/E 11.7
$28.27BUSDP/E 12.1
$23.01BUSDP/E 19.2
$20.24BUSD
$14.14BUSDP/E 110.6
$14.66BUSDP/E 21.1
$12.60BUSDP/E 22.8
$11.25BUSD
$10.26BUSDP/E 28.0
$8.59BUSDP/E 19.2
$7.17BUSDP/E 112.5
$7.09BUSDP/E 41.5
$6.92BUSD
$6.54BUSDP/E 24.3
$5.87BUSDP/E 77.1
APTX
Apotex Health Corp.$5.17BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
VVIA Empresa | ||
RRenta 4 | ||
VValencia Plaza | ||
RRevista Pharma Market | ||
Almirall SA (STU:E2Z) Q2 2026 Earnings Call Highlights: Strong Growth in Dermatology and ... Almirall SA (STU:E2Z) reports robust sales growth and improved financial metrics, despite challenges in the U.S. and Germany. | ||